In the news release, Notice of Cipher Pharmaceuticals Q2 2017 conference call, issued today at 09:32, please note that an error occurred in the headline which should read "Notice of Cipher Pharmaceuticals Q3 2017 conference call" not "Notice of Cipher Pharmaceuticals Q2 2017 conference call". The complete, corrected release follows:

Notice of Cipher Pharmaceuticals Q3 2017 conference call

MISSISSAUGA, ON, Oct. 17, 2017 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q3 2017 financial results conference call on Friday, November 3, 2017.

Q3 2017 CONFERENCE CALL

WHEN: Friday, November 3, 2017 at 8:30AM ET

CONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through www.cipherpharma.com or http://bit.ly/2zbTEna. An archived replay of the webcast will be available for 90 days.

About Cipher Pharmaceuticals Inc.

Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America.  For more information, visit www.cipherpharma.com. 

SOURCE Cipher Pharmaceuticals Inc.